Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,800
Closed -$169K 5472
2022
Q2
$190K Buy
+3,800
New +$202K 0.01% 1040
2022
Q1
Sell
-2,000
Closed -$103K 5984
2021
Q4
$100K Buy
+2,000
New +$98.9K ﹤0.01% 1854
2018
Q2
Sell
-22,100
Closed -$870K 4827
2018
Q1
$885K Buy
22,100
+21,024
+1,954% +$875K 0.08% 251
2017
Q4
$46K Buy
+1,076
New +$49.6K ﹤0.01% 1935
2017
Q1
Sell
-13,335
Closed -$566K 7143
2016
Q4
$539K Buy
+13,335
New +$525K 0.02% 657
2016
Q1
Sell
-1,000
Closed -$40.2K 7139
2015
Q4
$42K Buy
+1,000
New +$46K ﹤0.01% 2647

Other funds holding SNY

Cutler Group's SNY Position: Q3 2022 in Review

Cutler Group sold out of Sanofi (SNY) in Q3 2022, closing a stake of 3,800 shares — an estimated $169K sold.

Cutler Group first reported a position in SNY in Q4 2015 and held it in 6 quarters. The position peaked at $885K in Q1 2018. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Cutler Group reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 3,800 Sanofi shares in Q3 2022, an estimated $169K.
  • Cutler Group first reported a position in Sanofi in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Sanofi position peaked at $885K in Q1 2018.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.